Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Temporal Lobe Epilepsy Clinical Trials
Temporal Lobe Epilepsy clinical trials are recruiting across 97 cities. Here are the cities with the most active studies:
Temporal Lobe Epilepsy Trial Phases
48 research organizations are sponsoring temporal lobe epilepsy trials.
About Temporal Lobe Epilepsy
Temporal lobe epilepsy is the most common form of focal epilepsy, with seizures originating in the temporal lobe of the brain. It can cause unusual sensations, memory problems, and altered consciousness. Treatment includes antiseizure medications and surgery for drug-resistant cases.
Clinical trials are advancing new treatments for temporal lobe epilepsy. Currently, 61 studies are recruiting a combined 7,897 participants across the United States. Research is being conducted by 48 organizations including University of Pennsylvania, Eli Lilly and Company, University of California, Davis and 45 others.
2026 Temporal Lobe Epilepsy Research Landscape
As of July 2026, the temporal lobe epilepsy clinical trial landscape includes 61 actively recruiting studies across 97 cities in the United States. These studies are collectively seeking 7,897 participants, with an average enrollment target of 129 per study.
The research spans multiple phases of development: 28 studies are in PHASE2, 15 studies are in NA, 11 studies are in PHASE1, 8 studies are in PHASE3, 3 studies are in PHASE4. The presence of Phase 3 trials indicates that some temporal lobe epilepsy treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 48 different organizations, including University of Pennsylvania, Eli Lilly and Company, University of California, Davis, Alliance for Clinical Trials in Oncology, Rutgers, The State University of New Jersey, and 43 others. The large number of sponsors reflects significant research interest and investment in temporal lobe epilepsy treatment advancement.
Geographically, temporal lobe epilepsy trials are most concentrated in Duarte, California (9 trials); Rochester, Minnesota (8 trials); Philadelphia, Pennsylvania (7 trials); Chicago, Illinois (7 trials); Houston, Texas (7 trials) and 7 other cities.
Featured Temporal Lobe Epilepsy Studies
Highlighted recruiting studies for temporal lobe epilepsy, selected by enrollment size and research scope.
International Registry for Patients With Castleman Disease
The purpose of this study is to collect clinical, laboratory, and patient survey data from patients with Castleman disease to improve understanding, diagnosis, and treatment of the disease. Funding source - FDA OOPD.
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib. The clinical studies that will feed into this master protocol are referred to as originator studies. The master protocol will govern individual study-specific appendices (ISAs) that will represent pa...
Spatial Scene Recognition Memory in Epilepsy Surgery
This study investigates the anatomical and physiological basis of spatial scene recognition memory in patients with temporal lobe epilepsy and temporal lobe lesions. Standard neuropsychological tests are insensitive to important memory deficits experienced by patients, particularly in spatial/scene memory, recollective experience, and familiarity processing. Using a validated virtual tour paradigm...
Frequently Asked Questions About Temporal Lobe Epilepsy Clinical Trials
Are there temporal lobe epilepsy clinical trials near me?
Yes, there are 61 temporal lobe epilepsy clinical trials currently recruiting across 97+ cities in the United States, including Duarte, California; Rochester, Minnesota; Philadelphia, Pennsylvania. Browse the studies above to find one at a location convenient for you.
How do I join a temporal lobe epilepsy clinical trial?
To join a temporal lobe epilepsy clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are temporal lobe epilepsy clinical trials free?
Yes, participation in temporal lobe epilepsy clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of temporal lobe epilepsy treatments are being studied?
Current temporal lobe epilepsy clinical trials are testing a range of approaches across PHASE2 (28 studies), NA (15 studies), PHASE1 (11 studies), PHASE3 (8 studies), PHASE4 (3 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 48 research organizations.
Is it safe to participate in temporal lobe epilepsy clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 15, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 15, 2026 · Data from ClinicalTrials.gov